Page 17 - ஆராய்ச்சி உதவியாளர் ப்ரொஃபெஸர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Emergent Anthropology: Reimagining U S Medical Anthropology in Theory and Practice
somatosphere.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from somatosphere.net Daily Mail and Mail on Sunday newspapers.
Trường ĐH Khoa học Tự nhiên TP HCM công bố phương án tuyển sinh - Học hành
vietgiaitri.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietgiaitri.com Daily Mail and Mail on Sunday newspapers.
Zoltan Gombos, MD PhD, Joins Inoculate, LLC to Advance European HealthTech Entry into the US Market
Share Article CHAPEL HILL, N.C. (PRWEB) January 18, 2021 Zoltan Gombos, MD, PhD, joins Inoculate, LLC to advance European HealthTech entry into the US market. As medical innovation officer, Gombos brings tremendous experience and unique insight based on surgical and molecular pathology practice and clinical laboratory leadership. Gombos is also well published in many related peer-reviewed studies as PI or contributor, and serves as Research Assistant Professor at the University of Louisiana, Lafayette.
With familial origin in Eastern Europe and as Honorary Consul to the Slovak Republic, Gombos brings an extensive network and understanding of the challenges emerging European organizations face in addressing the US healthcare space.
UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases
Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators are reporting the results of a groundbreaking randomized controlled trial showing umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely reduce risk of death and quicken time to recovery for the most severe COVID-19 patients. Dr. Ricordi s peer-reviewed paper has just been published in
STEM CELLS Translational Medicine (SCTM) January 2021.
The clinical trial, authorized by the FDA last April, was initiated by The Cure Alliance, a 501(c)(3) non-profit organization of research scientists founded ten years ago by Dr. Ricordi for scientists around the world to share knowledge and accelerate cures of all diseases.
vimarsana © 2020. All Rights Reserved.